Delivery Order SPE2DB22D3401-SPE2DB26FT0TB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $17,707.09. This is a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,649.19. This non-set-aside delivery order, with an ultimate completion date of August 29, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.91 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a direct pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) valued at $10,374.06. This is a firm fixed-price delivery order with a completion date of October 31, 2025, and was competitively awarded without set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,948.10 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) at a ceiling value of $3,346.62. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by October 21, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,828.40. This non-set-aside, competitively awarded delivery order has an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units under a firm fixed-price contract. The contract ceiling value is $8,651.75 and represents performance at the contractor's headquarters location in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0TBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30, with a contract ceiling value of $2,828.40. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on November 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents no set-aside designation, indicating open competition among eligible contractors. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive portfolio of medications and medical commodities to support military and veteran healthcare systems globally. The Vemlidy tablets procured under this delivery order represent a specialty pharmaceutical product within the broader scope of the company's federal contracting activities with the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/6/25 |